Developing a blood-based biomarker panel for early screening of Alzheimer’s disease
Joyce Ouyang is a Postdoctoral Fellow at the Hong Kong University of Science and Technology (Hong Kong, China) whose research focuses on diagnostic and therapeutic targets for Alzheimer’s disease (AD). At the Society for Neuroscience annual meeting (SfN; 11–15 November 2023, Washington DC, USA), Ouyang presented a poster on developing a blood-based biomarker panel for the early screening and classification of AD. Digital Editor Annie Coulson had a chance to chat with Ouyang about her poster and research at SfN. What did you present at SfN? I presented a poster about the biomarker panel we developed, which is an integrated...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
